Listen
ONBREZ BREEZHALER - OSLIF BREEZHALER - HIROBRIZ BREEZHALER
-
Opinions on drugs -
Posted on
May 05 2011
Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
-
Clinical Benefit
| Substantial |
The actual benefit of HIROBRIZ BREEZHALER 150 μg and 300 μg is substantial. |
Clinical Added Value
| no clinical added value |
HIROBRIZ BREEZHALER 150 μg and 300 μg provide no improvement in actual benefit (IAB V) compared to the other long-acting bronchodilators indicated for COPD. |
Documents
English version
Contact Us
Évaluation des médicaments
